Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03619863 · ClinicalTrials.gov registry record
ATHN 7: Hemophilia Natural History Study
A clinical trial, sponsored by American Thrombosis and Hemostasis Network.
- Completed
- Registry status
- 395
- Enrollment target
NCT03619863: Completed study, sponsored by American Thrombosis and Hemostasis Network.
NCT03619863 is a clinical trial that has completed, run by American Thrombosis and Hemostasis Network. The registered enrollment target is 395 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03619863 has completed, sponsored by American Thrombosis and Hemostasis Network.
- COMPLETED
- Registry status
- 395 participants
- Enrollment target
Study Summary
This is a real-world study of the safety of the treatments used for people with hemophilia. The study will follow people with hemophilia A or B from across the country for about 4 years as they receive treatment. The hemophilia treatment center (HTC) physician and participant will decide on the FDA-approved treatment to be used which may include non-factor products, bypassing agents, or clotting factor replacement products. The goal of this research is to study the use of hemophilia treatment products and their outcomes.
Primary Outcome
All treatment-related reportable adverse events will be documented on the ATHN Adverse Event Module Form based on EUHASS reportable events which include: death, factor inhibitor development, venous thrombosis, allergic reactions, treatment-emergent side effects, new malignancies, cardiovascular events, and blood-borne infections. Other treatment-related events to be documented on the ATHN Adverse Event Module Form including thrombotic microangiopathies, injection site reactions, drug-induced liv
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 395 participants |
| Start Date | 2018-10-24 |
| Est. Completion | 2024-03-31 |
What the finished NCT03619863 record still lists
NCT03619863 is an observational study that tracks outcomes without assigning an intervention. The registered 395 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT03619863 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03619863 about?
NCT03619863 is a clinical study titled "ATHN 7: Hemophilia Natural History Study". This is a real-world study of the safety of the treatments used for people with hemophilia. The study will follow people with hemophilia A or B from across the country for about 4 years as they receive treatment. The hemophilia treatment center (HTC) physician and participant will decide on the FDA-...
What is the current status of trial NCT03619863?
This trial is currently completed. The enrollment target is 395 participants. The study started on 2018-10-24. Estimated completion is 2024-03-31.
Who is sponsoring clinical trial NCT03619863?
This trial is sponsored by American Thrombosis and Hemostasis Network, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07207369 · 395 participants · Phase 3
A Study to Assess the Safety and Effectiveness of ELAPR002f Injectable Gel in Adult Participants With Atrophic Acne Scars
- NCT05633615 · 396 participants · Phase 2
Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
- NCT06227910 · 396 participants · Phase 3
A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease
- NCT06545331 · 396 participants · Phase 1
Study of XB010 in Subjects With Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI